Simptomtiska rstana: Pacientiem ar ievrojamu sirdsdarbbas truma palielinanos var ievadt atbilstou sirdsdarbbas trumu reguljou medikamentu (piemram, beta blokatoru) lietoanu GLP-1 simptomtiska spiediena izmaiu rsta vadb
It helps curb hunger and creates a feeling of fullness with smaller portions, making it easier to maintain a calorie deficit and achieve weight loss
Hou Y, Ernst SA, Heidenreich K, and Williams JA
By linking multi-omic laboratory discoveries with patient-based investigation, our findings highlight the potential for GLP-1RAs to be repurposed as a new therapeutic indication in stroke treatment.
Recognizing the potential of semaglutide for weight management, researchers developed Wegovy, a higher-dose version of semaglutide approved in 2021 explicitly for chronic weight management in patients with obesity or overweight with at least one weight-related comorbidity